SQSP
SQUARESPACE INC
No data for this timeframe.
Vol
Inst. Holders1 funds
Inst. Value$4.9M
Inst. Activity0 buys / 12 sells
SEC Reports1
Recent Activity
Feb 28, 2026
SEC
Three major passive institutional investors — Morgan Stanley, Wells Fargo, and Schwab — completely exited their position
INST-CLUSTER — Impact 7/10
Inst.
MORGAN STANLEY — EXIT
0 shares ($0.00)
Inst.
STATE STREET CORP — EXIT
0 shares ($0.00)
Analyst Ratings
3Strong Buy
4Buy
11Hold
0Sell
0Strong Sell
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| BARCLAYS PLC | $4.9M | — |
1 institutional holders with $4.9M total value (104,510 shares) as of 2025-Q3. Top holders: BARCLAYS.
Top Institutional Holders — 2025-Q3
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | BARCLAYS PLC | 104,510 | $4.9M | 100.0% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| MORGAN STANLEY | EXIT | 362,633 | 0 | -100.0% | $0.00 | 2024-Q4 |
| STATE STREET CORP | EXIT | 1,328,016 | 0 | -100.0% | $0.00 | 2024-Q4 |
| WELLINGTON MANAGEMENT GROUP LLP | EXIT | 5,245,888 | 0 | -100.0% | $0.00 | 2024-Q4 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | EXIT | 536,593 | 0 | -100.0% | $0.00 | 2024-Q4 |
| VANGUARD GROUP INC | EXIT | 7,480,314 | 0 | -100.0% | $0.00 | 2024-Q4 |
| BlackRock, Inc. | EXIT | 5,197,281 | 0 | -100.0% | $0.00 | 2024-Q4 |
| FIL Ltd | EXIT | 3,625,225 | 0 | -100.0% | $0.00 | 2024-Q4 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | EXIT | 709,572 | 0 | -100.0% | $0.00 | 2024-Q4 |
| BALYASNY ASSET MANAGEMENT L.P. | EXIT | 1,674,792 | 0 | -100.0% | $0.00 | 2024-Q4 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | EXIT | 840,548 | 0 | -100.0% | $0.00 | 2024-Q4 |
| FARALLON CAPITAL MANAGEMENT LLC | EXIT | 2,891,632 | 0 | -100.0% | $0.00 | 2024-Q4 |
| BANK OF AMERICA CORP /DE/ | EXIT | 425,619 | 0 | -100.0% | $0.00 | 2024-Q4 |
| FIL Ltd | DOUBLED | 208,000 | 3,625,225 | +1642.9% | $168.3M | 2024-Q3 |
| FARALLON CAPITAL MANAGEMENT LLC | NEW | — | 2,891,632 | — | $134.3M | 2024-Q3 |
| BALYASNY ASSET MANAGEMENT L.P. | ADD | 962,313 | 1,674,792 | +74.0% | $77.8M | 2024-Q3 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | DOUBLED | 260,581 | 709,572 | +172.3% | $32.9M | 2024-Q3 |
| MORGAN STANLEY | ADD | 264,115 | 362,633 | +37.3% | $16.8M | 2024-Q3 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | DOUBLED | 80,558 | 190,951 | +137.0% | $8.9M | 2024-Q3 |
| Verition Fund Management LLC | DOUBLED | 8,163 | 185,349 | +2170.6% | $8.6M | 2024-Q3 |
| GABELLI FUNDS LLC | TRIM | 295,087 | 157,905 | -46.5% | $7.3M | 2024-Q3 |
| Russell Investments Group, Ltd. | DOUBLED | 324 | 38,950 | +11921.6% | $1.8M | 2024-Q3 |
| OMERS ADMINISTRATION Corp | DOUBLED | 16,300 | 37,100 | +127.6% | $1.7M | 2024-Q3 |
| DIMENSIONAL FUND ADVISORS LP | TRIM | 64,450 | 32,409 | -49.7% | $1.5M | 2024-Q3 |
| D. E. Shaw & Co., Inc. | TRIM | 82,559 | 31,879 | -61.4% | $1.5M | 2024-Q3 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | TRIM | 49,561 | 31,477 | -36.5% | $1.5M | 2024-Q3 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
1 SEC filing reports analyzed. Sentiment: 0 bullish, 1 bearish, 0 mixed, 0 neutral. Avg impact: 7.0/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 39% buy across 18 analysts — 3 strong buy, 4 buy, 11 hold, 0 sell, 0 strong sell. No current recommendation available.
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jan 1, 2025 | 3 | 4 | 11 | 0 | 0 | 39% | |
| Dec 1, 2024 | 3 | 4 | 11 | 0 | 0 | 39% | |
| Nov 1, 2024 | 3 | 4 | 11 | 0 | 0 | 39% | |
| Oct 1, 2024 | 3 | 4 | 11 | 0 | 0 | 39% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.